High-dose cyclophosphamide reduces disease activity and disability in MS
Treatment with high doses of the immunosuppressant drug cyclophosphamide (HiCy) appears to reduce disease activity and disability in individuals with aggressive multiple sclerosis, according to new research....
Want to read complete article? Please Sign in or Register.